US Patent Issued to Fate Therapeutics on Aug. 12 for "Methods and compositions for inducing hematopoietic cell differentiation" (California Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,385,012, issued on Aug. 12, was assigned to Fate Therapeutics Inc. (San Diego).

"Methods and compositions for inducing hematopoietic cell differentiation" was invented by Bahram Valamehr (San Diego) and Raedun Clarke (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides culture platforms, cell media, and methods of differentiating pluriptent cells into hematopoietic cells. The invention further provides pluripotent stem cell-derived hematopoietic cells generated using the culture platforms and methods disclosed herein, which enable feed-free, monolayer culturing and in the absence of EB formation. Specifically, pluripotent ste...